Stromal SOX2 Upregulation Promotes Tumorigenesis through the Generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population

Cancer-associated fibroblasts (CAFs) promote tumor malignancy, but the precise transcriptional mechanisms regulating the acquisition of the CAF phenotype are not well understood. We show that the upregulation of SOX2 is central to this process, which is repressed by protein kinase Cζ (PKCζ). PKCζ de...

Full description

Saved in:
Bibliographic Details
Published inDevelopmental cell Vol. 56; no. 1; pp. 95 - 110.e10
Main Authors Kasashima, Hiroaki, Duran, Angeles, Martinez-Ordoñez, Anxo, Nakanishi, Yuki, Kinoshita, Hiroto, Linares, Juan F., Reina-Campos, Miguel, Kudo, Yotaro, L’Hermitte, Antoine, Yashiro, Masakazu, Ohira, Masaichi, Bao, Fei, Tauriello, Daniele V.F., Batlle, Eduard, Diaz-Meco, Maria T., Moscat, Jorge
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 11.01.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cancer-associated fibroblasts (CAFs) promote tumor malignancy, but the precise transcriptional mechanisms regulating the acquisition of the CAF phenotype are not well understood. We show that the upregulation of SOX2 is central to this process, which is repressed by protein kinase Cζ (PKCζ). PKCζ deficiency activates the reprogramming of colonic fibroblasts to generate a predominant SOX2-dependent CAF population expressing the WNT regulator Sfrp2 as its top biomarker. SOX2 directly binds the Sfrp1/2 promoters, and the inactivation of Sox2 or Sfrp1/2 in CAFs impaired the induction of migration and invasion of colon cancer cells, as well as their tumorigenicity in vivo. Importantly, recurrence-free and overall survival of colorectal cancer (CRC) patients negatively correlates with stromal PKCζ levels. Also, SOX2 expression in the stroma is associated with CRC T invasion and worse prognosis of recurrence-free survival. Therefore, the PKCζ-SOX2 axis emerges as a critical step in the control of CAF pro-tumorigenic potential. [Display omitted] •PKCζ is lost in the stroma of poor-prognosis mesenchymal human CMS4 CRC•Stromal loss of PKCζ upregulates SOX2 to promote the CAF phenotype•Selective deletion of PKCζ in fibroblast activates the SOX2/SFRP1/2 axis in vivo•Stromal SOX2 negatively correlates with PKCζ and predicts poor survival in CRC Kasashima et al. describe a molecular mechanism whereby the loss of PKCζ in the stroma upregulates SOX2 to activate the reprogramming of colonic fibroblasts generating a SFRP1/2-expressing CAF population. This population supports epithelial tumor progression, revealing vulnerabilities in mesenchymal CMS4 colorectal cancer.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1534-5807
1878-1551
1878-1551
DOI:10.1016/j.devcel.2020.10.014